Published in Ann Surg on September 01, 1987
Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg (1990) 7.04
Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg (1996) 4.51
Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg (1995) 4.17
Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut (2005) 2.07
Factors predictive of survival in ampullary carcinoma. Ann Surg (1998) 2.06
Pancreatic cancer in 1988. Possibilities and probabilities. Ann Surg (1988) 1.83
Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. World J Gastroenterol (2011) 1.65
Pancreatic cancer cell DNA content correlates with long-term survival after pancreatoduodenectomy. Ann Surg (1991) 1.55
Current management of pancreatic carcinoma. Ann Surg (1995) 1.54
Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut (1994) 1.34
Effect of matrix metalloproteinase inhibition on pancreatic cancer invasion and metastasis: an additive strategy for cancer control. Ann Surg (2000) 1.10
Clinical behavior and prognostic factors of periampullary adenocarcinoma. Ann Surg (1995) 1.03
Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma. Br J Cancer (2002) 1.03
Neurotensin regulates growth of human pancreatic cancer. Ann Surg (1993) 1.02
EUS mini probes in diagnosis of cystic dystrophy of duodenal wall in heterotopic pancreas: a case report. World J Gastroenterol (2004) 0.98
Vascular invasion in pancreatic cancer: Imaging modalities, preoperative diagnosis and surgical management. World J Gastroenterol (2010) 0.96
Diagnosing cancer of the pancreas. BMJ (1990) 0.96
Epithelial markers in pancreatic carcinoma: immunoperoxidase localisation of DD9, CEA, EMA and CAM 5.2. J Clin Pathol (1990) 0.90
Influence of site of origin and mucin production on survival in ampullary carcinoma. Ann Surg (1989) 0.86
Long-term survival in patients with pancreatic ductal adenocarcinoma. Surgery (2016) 0.81
Laparoscopic robot-assisted versus open total pancreatectomy: a case-matched study. Surg Endosc (2014) 0.80
Anaplastic carcinoma of the pancreas mimicking submucosal gastric tumor: a case report of a rare tumor. Case Rep Med (2013) 0.79
How to pass on expertise: pancreatoduodenectomy at a teaching hospital. World J Surg (2002) 0.79
Can pancreaticoduodenectomy performed at a comprehensive community cancer center have comparable results as major tertiary center? J Gastrointest Oncol (2011) 0.78
Electrolytic ablation of the rat pancreas: a feasibility trial. BMC Gastroenterol (2001) 0.77
Physician attitudes and treatment patterns for pancreatic cancer. World J Surg Oncol (2011) 0.77
Angiotensin-II administration is useful for the detection of liver metastasis from pancreatic cancer during pharmacoangiographic computed tomography. World J Gastroenterol (2007) 0.77
Is it relevant that intra-arterial chemotherapy may be effective for advanced pancreatic cancer? World J Gastroenterol (2007) 0.76
Is the Whipple procedure a better palliative option for pancreatic cancer? J Natl Med Assoc (1991) 0.76
A case of long-term 24-month survival in pancreatic anaplastic carcinoma (giant cell type) after S1 postoperative adjuvant chemotherapy. Int J Surg Case Rep (2016) 0.75
RADICAL PANCREATODUODENECTOMY: A 22-YEAR EXPERIENCE WITH THE COMPLICATIONS, MORTALITY RATE, AND SURVIVAL RATE. Ann Surg (1964) 4.26
Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma). A clinicopathologic study of 41 cases. Am J Clin Pathol (1978) 3.88
Pancreatico-duodenectomy: forty-one consecutive Whipple resections without an operative mortality. Ann Surg (1968) 3.34
Factors influencing morbidity and mortality in pancreaticoduodenectomy. Ann Surg (1973) 2.73
Surgical experience with pancreatic and periampullary cancer. Ann Surg (1982) 2.09
Considerations that lower pancreatoduodenectomy mortality. Am J Surg (1977) 2.08
Surgical treatment of cancer of the pancreas and the periampullary region: cumulative results in 57 institutions in Japan. Ann Surg (1977) 1.92
Total pancreatectomy for ductal adenocarcinoma of the pancreas. Mayo Clinic experience. Am J Surg (1981) 1.90
Carcinoma of the pancreas and periampullary region. Ann Surg (1979) 1.87
Importance of pathologic staging in the surgical management of adenocarcinoma of the exocrine pancreas. Am J Surg (1974) 1.70
Cancer statistics. 1986. CA Cancer J Clin (1987) 1.67
Pancreatic resection for carcinoma of the pancreas: Whipple versus total pancreatectomy--an institutional perspective. World J Surg (1984) 1.61
Proceedings: Periampullary carcinoma. Arch Surg (1974) 1.48
Pancreatoduodenal resection and total pnacreatectomy--an institutional review. Surgery (1981) 1.48
The diagnosis of "early" pancreatic cancer: the University of Chicago experience. Cancer (1981) 1.32
A clinicopathologic study of 21 cases of pancreatic cystadenocarcinoma. Ann Surg (1978) 1.32
Factors influencing survival after total pancreatectomy in patients with pancreatic cancer. Ann Surg (1983) 1.27
Pancreatoduodenectomy for resectable malignant periampullary tumors. Surg Gynecol Obstet (1983) 1.26
Comparison of conventional surgical resection, radioactive implantation, and bypass procedures for exocrine carcinoma of the pancreas 1975-1980. Ann Surg (1984) 1.21
Pancreatic and periampullary carcinoma. Experience with 200 patients over a 12 year period. Am J Surg (1982) 1.15
Results of operations of the Whipple type in pancreaticoduodenal carcinoma. Ann Surg (1957) 1.13
Improving survival in adenocarcinoma of the duodenum. Am J Surg (1981) 1.11
Pancreatoduodenectomy. Results when the operation is performed infrequently. Arch Surg (1975) 1.05
The surgical aspects of insulinomas. Ann Surg (1979) 0.96
Follow-up studies of radical resection for pancreaticoduodenal cancer. Ann Surg (1977) 0.96
Cancer of the head of the pancreas and choledochoduodenal junction: a clinical study of 88 Whipple resections. Acta Chir Scand (1981) 0.88
Operative finding, treatment, and prognosis of carcinoma of the pancreas: an analysis of 267 cases. J Surg Oncol (1983) 0.86
Pancreatoduodenal resection; comments on indications, operative diagnosis, staged procedures, morbid and lethal factors, and survivals. Ann Surg (1958) 0.84
A retrospective study of carcinoma of the pancreas with special reference to the results of surgical treatment. Acta Chir Scand Suppl (1978) 0.84
Operative mortality following surgery for carcinoma of the pancreas. Aust N Z J Surg (1980) 0.81
Carcinoma of the pancreas: diagnosis and treatment. South Med J (1982) 0.81
The results of surgery for carcinoma of the pancreas. Aust N Z J Surg (1980) 0.81
A ten-year study of carcinoma of the pancreas. Am Surg (1977) 0.80
Pancreaticoduodenal resection. Report of 75 cases. Chin Med J (Engl) (1982) 0.80
Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med (1994) 6.05
Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Treat (2001) 3.77
MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. J Natl Cancer Inst (2000) 3.44
Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc Natl Acad Sci U S A (2000) 3.24
Xenograft model of progressive human proliferative breast disease. J Natl Cancer Inst (1993) 3.03
Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer. J Gastrointest Surg (2008) 2.41
Serum enzymes and other laboratory tests in acute pancreatitis. Br J Surg (1989) 2.28
Imaging of primary and metastatic pancreatic cancer using a fluorophore-conjugated anti-CA19-9 antibody for surgical navigation. World J Surg (2008) 2.27
Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res (2002) 2.11
The original illustrations of Hodgkin's disease. Arch Intern Med (1968) 2.07
Nascent blood vessels in the skin arise from nestin-expressing hair-follicle cells. Proc Natl Acad Sci U S A (2004) 2.00
Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. Cancer Res (1997) 2.00
Dual-color fluorescence imaging distinguishes tumor cells from induced host angiogenic vessels and stromal cells. Proc Natl Acad Sci U S A (2003) 1.98
A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. J Surg Res (2003) 1.82
Relationship between Friend virus and an associated lymphatic leukaemia virus. Br J Cancer (1968) 1.73
Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg (2000) 1.73
Visualizing gene expression by whole-body fluorescence imaging. Proc Natl Acad Sci U S A (2000) 1.72
Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct. Ann Surg (1989) 1.67
Spatial-temporal imaging of bacterial infection and antibiotic response in intact animals. Proc Natl Acad Sci U S A (2001) 1.59
Laser and laparoscopic cholecystectomy. A hazardous union? Arch Surg (1991) 1.57
Widespread skeletal metastatic potential of human lung cancer revealed by green fluorescent protein expression. Cancer Res (1998) 1.55
Chemical treatment of stones in the biliary tree. Br J Surg (1986) 1.53
A prospective study of glucose tolerance, insulin, C-peptide, and glucagon responses in patients with pancreatic carcinoma. Am J Dig Dis (1978) 1.51
Determinants of the reversal time of competitive neuromuscular block by anticholinesterases. Br J Anaesth (1991) 1.50
Gastrointestinal hemorrhage from left-sided portal hypertension. An unappreciated complication of pancreatitis. Am J Surg (1981) 1.46
Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes (1994) 1.46
A fluorescent orthotopic bone metastasis model of human prostate cancer. Cancer Res (1999) 1.46
Characterization of epithelial phenotypes in mortal and immortal human breast cells. Int J Cancer (1992) 1.42
Recombinant interferon alpha-2b in the management of malignant pleural effusions. Chest (1997) 1.40
Real-time imaging of tumor-cell shedding and trafficking in lymphatic channels. Cancer Res (2007) 1.39
Progression of premalignant MCF10AT generates heterogeneous malignant variants with characteristic histologic types and immunohistochemical markers. Breast Cancer Res Treat (2000) 1.39
Effect of pancreas allografts on the ultrastructure of sciatic nerves in diabetic rats. Microsurgery (1990) 1.39
Efficiency measurement of health care: a review of non-parametric methods and applications. Health Care Manag Sci (1999) 1.39
The effects of premedication drugs on the lower oesophageal high pressure zone and reflux status of rhesus monkeys and man. Gut (1975) 1.38
Development of a high metastatic orthotopic model of human renal cell carcinoma in nude mice: benefits of fragment implantation compared to cell-suspension injection. Clin Exp Metastasis (1999) 1.38
Chronologically-specific metastatic targeting of human pancreatic tumors in orthotopic models. Clin Exp Metastasis (2000) 1.38
In vivo tumor delivery of the green fluorescent protein gene to report future occurrence of metastasis. Cancer Gene Ther (2000) 1.37
Real-time in vivo dual-color imaging of intracapillary cancer cell and nucleus deformation and migration. Cancer Res (2005) 1.35
Treatment of obstructing cancer of the colon and rectum. Surg Gynecol Obstet (1975) 1.35
Assessment of tumor cell kinetics by immunohistochemistry in carcinoma of breast. Cancer (1987) 1.34
Factors influencing survival after resection for periampullary neoplasms. Am J Surg (2000) 1.34
Surgical treatment of pancreatic cancer. Mayo Clin Proc (1979) 1.32
The diagnosis of "early" pancreatic cancer: the University of Chicago experience. Cancer (1981) 1.32
Isolated splenic vein thrombosis. World J Surg (1985) 1.32
Pancreatic pseudocysts in children. J R Coll Surg Edinb (1974) 1.30
Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction. J Clin Invest (1983) 1.30
The hematologic characteristics of sickle cell anemia bearing the Bantu haplotype: the relationship between G gamma and HbF level. Blood (1987) 1.29
Dual-color imaging of nascent blood vessels vascularizing pancreatic cancer in an orthotopic model demonstrates antiangiogenesis efficacy of gemcitabine. J Surg Res (2006) 1.28
Purification, partial characterization, and clinical evaluation of a pancreatic oncofetal antigen. Cancer Res (1978) 1.27
Whole-body and intravital optical imaging of angiogenesis in orthotopically implanted tumors. Proc Natl Acad Sci U S A (2001) 1.26
Osteoclast-like giant cell tumor of the pancreas: immunophenotypic similarity to giant cell tumor of bone. Hum Pathol (1991) 1.24
Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction. Science (1982) 1.23
Real-time confocal imaging of trafficking of nestin-expressing multipotent stem cells in mouse whiskers in long-term 3-D histoculture. In Vitro Cell Dev Biol Anim (2012) 1.23
A reappraisal of the value of carcinoembryonic antigen in the management of patients with various neoplasms. Br J Surg (1979) 1.21
Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma. Clin Cancer Res (1995) 1.21
Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg (1996) 1.20
Aorto-iliac reconstruction with special reference to the extraperitoneal approach. Br J Surg (1975) 1.20
Direct external imaging of nascent cancer, tumor progression, angiogenesis, and metastasis on internal organs in the fluorescent orthotopic model. Proc Natl Acad Sci U S A (2002) 1.20
Liver colonization competence governs colon cancer metastasis. Proc Natl Acad Sci U S A (1995) 1.17
Total mesenteric excision in the surgical treatment of rectal cancer: a prospective study. Arch Surg (1998) 1.17
Lymphatic leukaemia in rats and mice inoculated with Friend virus. Br J Cancer (1966) 1.17
Fluorescent LYVE-1 antibody to image dynamically lymphatic trafficking of cancer cells in vivo. J Surg Res (2008) 1.16
Regional lymph node dissection for malignant melanoma of the extremities. Surgery (1981) 1.16
Monoclonal antibody to intermediate filament antigen cross-reacts with higher plant cells. J Cell Biol (1985) 1.16
Gastro-oesophageal reflux and hiatal hernia. A re-evaluation of current data and dogma. Ann R Coll Surg Engl (1976) 1.14
Current concepts. Diagnostic tests and procedures in acute pancreatitis. N Engl J Med (1984) 1.13
The prognosis of carcinoma of the colon and rectum complicating ulcerative colitis. Surg Gynecol Obstet (1978) 1.13
Management of pancreatic trauma. Ann R Coll Surg Engl (1983) 1.12
Genetically fluorescent melanoma bone and organ metastasis models. Clin Cancer Res (1999) 1.12
An orthotopic mouse model of remetastasis of human colon cancer liver metastasis. Clin Cancer Res (2000) 1.12
Optically imageable metastatic model of human breast cancer. Clin Exp Metastasis (2002) 1.11
Metastatic patterns of lung cancer visualized live and in process by green fluorescence protein expression. Clin Exp Metastasis (1997) 1.10
Intraluminal and intraperitoneal pressures at the cardia: effect of hormones and surgical intervention. Surg Forum (1973) 1.08
An imageable highly metastatic orthotopic red fluorescent protein model of pancreatic cancer. Clin Exp Metastasis (2004) 1.08
Kinetics of insulin action in vivo. Identification of rate-limiting steps. Diabetes (1995) 1.08
Hepatic metabolism of glucagon in the dog: contribution of the liver to overall metabolic disposal of glucagon. Am J Physiol (1981) 1.08
Comparative value of four methods of investigating the pancreas. Surgery (1976) 1.07
The role of interventional radiology for complications of cholecystectomy. Surgery (1990) 1.07
Complications of laparoscopic cholecystectomy: coordinated radiologic and surgical management in 21 patients. Radiology (1993) 1.06
Rectal excision with coloanal anastomosis for superficial distal third rectal cancer: survival and local recurrence. Colorectal Dis (2001) 1.05
Differences in the hepatic and renal extraction of insulin and glucagon in the dog: evidence for saturability of insulin metabolism. Acta Endocrinol (Copenh) (1983) 1.04
Factors influencing local recurrence after abdominoperineal resection for cancer of the rectum and rectosigmoid. Br J Surg (1975) 1.04
Management of tumor adherent to the vertebral column. J Thorac Cardiovasc Surg (1989) 1.04
Evidence for a common molecular pathogenesis in colorectal, gastric, and pancreatic cancer. Genes Chromosomes Cancer (1991) 1.03
The pathological findings of breast cancer in patients surviving 25 years after radical mastectomy. Cancer (1982) 1.03
Incidence and therapeutic implications of synchronous colonic pathology in colorectal adenocarcinoma. Surgery (1997) 1.03
Determination of clonality of metastasis by cell-specific color-coded fluorescent-protein imaging. Cancer Res (2003) 1.02
Virus-free Friend virus-induced tumor: in vitro and in vivo characteristics. J Natl Cancer Inst (1966) 1.02
The MCF10 family of spontaneously immortalized human breast epithelial cell lines: models of neoplastic progression. Eur J Cancer Prev (1993) 1.01
Hepatic resection: effective treatment for primary and secondary tumors. Surgery (2000) 1.01
Host organ specifically determines cancer progression. Cancer Res (1995) 1.00
Growth and regression of human tumor cell lines in congenitally athymic (rnu/rnu) rats. J Natl Cancer Inst (1981) 1.00
Methioninase cancer gene therapy with selenomethionine as suicide prodrug substrate. Cancer Res (2001) 1.00
Prospective study of the features, indications, and surgical treatment in 513 consecutive patients affected by Crohn's disease. Surgery (1997) 1.00
Relationship of P-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNA ploidy, and disease relapse. Cancer (1994) 0.99
Deletion mapping reveals two regions of chromosome 8 allele loss in colorectal carcinomas. Genes Chromosomes Cancer (1994) 0.99
Central relaxin-3 administration causes hyperphagia in male Wistar rats. Endocrinology (2005) 0.99
Reduction in portal vein blood flow by somatostatin. Diabetes (1979) 0.99
A highly metastatic Lewis lung carcinoma orthotopic green fluorescent protein model. Clin Exp Metastasis (2000) 0.99